as on January 23, 2026 at 4:01 pm IST
Day's Low
4.47%
Downside
52 Week's Low
52 Week's High
21.95%
Downside
65.06%
Upside
as on January 23, 2026 at 4:01 pm IST
Market Cap
₹66.59 Cr
Return on Equity (ROE)
16.88
PE Ratio (TTM)
27.76
Return on capital employed (ROCE)
11.71
Industry PE ratio
46.27
Beta (LTM)
0.57
P/B Ratio
12.04
Dividend Yield
0PEG Ratio
8
Quarterly Earnings Growth YOY
740
EPS (TTM)
1.97
Sector
Healthcare
Book Value
7.03
Technical Analysis
Bullish
View Technical Analysis
as on January 23, 2026 at 4:01 pm IST
Aspira Pathlab in the last 5 years
Lowest (-433.33x)
November 29, 2024
Today (27.76x)
January 23, 2026
Industry (46.27x)
January 23, 2026
Highest (124.02x)
March 24, 2025
Today’s Price to Earnings Ratio: 27.76x
Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 66.59 | 28.37% | 0.58 | 2 | 22 | |
| BUY | 10,251.60 | 12.13% | 0.65 | 143 | 704 | |
| NA | 3,049.75 | 15.1% | 0.51 | -161 | 6 | |
| NA | 56.88 | 260.18% | 0.64 | 3 | 16 | |
| BUY | 21,911.85 | -1.44% | 0.58 | 496 | 3,642 |
Get share price movements and forecasts by analysts on Aspira Pathlab.
Source: S&P Global Market Intelligence
Search interest for Aspira Pathlab & Diagnostics Ltd Stock has increased by 84% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:84% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aspira Pathlab.
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Aspira Pathlab stock has moved up by 1.1%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 81.61% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Fortis Healthcare Ltd has given 37.0% return, outperforming this stock by 53.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 18.39% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 199.4% return, outperforming this stock by 141.6%
| Organisation | Aspira Pathlab & Diagnostics Ltd |
| Headquarters | Mumbai |
| Industry | Healthcare |
| CEO | Haseeb Drabu |
| E-voting on shares | Click here to vote |
Aspira Pathlab share price today stands at ₹64.69 as on at the close of the market. Aspira Pathlab share today touched a day high of ₹64.69 and a low of ₹61.8.
Aspira Pathlab touched a 52 week high of ₹106.78 and a 52 week low of ₹50.49. Aspira Pathlab share price today i.e. is closed at ₹64.69, which is -39.42% down from its 52 week high and 28.12% up from its 52 week low.
Aspira Pathlab market capitalisation is ₹66.59 Cr as on .
To buy Aspira Pathlab shares, you need to follow these steps:
Aspira Pathlab trading volume is 10.00 as on . This means that 10.00 shares of Aspira Pathlab were bought and sold on the stock market during today's trading session.